A total population study of the ocular status of all known non-insulin-treated diabetic patients resident in the English town of Melton Mowbray has been conducted.
Diabetic retinopathy is a leading cause of visual impair ment among people of working age in Western society.I-3 Precise quantification of the prevalence of diabetic ret inopathy in different communities is important for the planning and provision of health services both locally and nationally. Numerous studies have investigated the epi demiology of background and proliferative diabetic ret inopathy, 4-13 but there have been few studies which specifically examine the epidemiology of diabetic maculopathy. [14] [15] [16] The identification of risk factors is important for the evolution of better management strategies for diabetic ret inopathy. From previous studies possible risk factors for retinopathy in general have included diabetic duration, glycaemic control (blood glucose and glycosylated hae- Eye (1993) 7, 158-163 moglobin), type of diabetes (age at onset), diabetic treat ment (insulin, oral hypoglycaemic, dietary), systemic hypertension, renal function/nephropathy, body mass, sex, HLA status, cigarette smoking, and elevated blood lipids.4,s,9-13,1&-24 Despite the recognised importance of maculopathy as a cause of visual morbidity in diabetes,2.3,2s , 26 risk factors for diabetic maculopathy have received considerably less attention in the literature. Dia betic duration, age, sex, age at diagnosis, insulin use, higher glycosylated haemoglobin, diuretic use, systemic hypertension and proteinuria have been associated with diabetic macular oedema. 1 4 , 16 In this study of a total popUlation we report the preva lence and risk factors for diabetic retinopathy and diabetic macular oedema in the non-insulin-treated diabetics resi dent in the English market town of Melton Mowbray. Non-insulin-treated diabetics comprise the greater pro portion of diabetics in the community, and quantification of the impact of diabetes on their visual status is relevant in terms of identification of need for care and service pro vision. This work completes the earlier report on the insulin-treated diabetics of this town,16 and together these two studies provide a reasonably complete statement on the ocular status of all known diabetics in this geographi cally well-defined community.
METHOD

Population
Melton Mowbray in Leicestershire is served by a single large general practice. An age/sex register of all patients registered with the town's practice is maintain.ed by the Department of Epidemiology and Public Health of the University of Leicester. The town is demographically similar to Englanq and Wales as a whole,27 and has a popu lation of a little over 32,000. All known diabetics in the town were identified and invited to participate in an ocular examination. A previous report has described the method of ascertainment of the subjects and the findings for the insulin-treated group. 16 
Patient Assessment
The details of the method of examination have been described. 16 Briefly, participants underwent a medical history, blood pressure measurement (Copal U-231 auto matic sphygmomanometer), standard ocular refraction, slit lamp examination,. direct and indirect ophthalmo scopic fundus examination through dilated pupils and 7-field stereo fundus' photography. Stereo fundus photo graphs were graded by two independent observers. When disagreements occurred a consensus was reached by dis cussion and review of the images. Retinopathy was graded using the Wisconsin method,1O and maculopathy was graded separately using a slightly modified version of the ETDRS method. Clinically significant maculopathy was graded in the standard €TDRS manner,28 with an addi tional category being employed to describe the presence of maculopathy which was non-clinically significant (defined as haemorrhages, exudates or microaneurysms within 500 11m of the fovea but without retinal thick ening). Laser scars near the fovea were regarded as clini cally significant maculopathy which had been treated. As many patients who had undergone laser treatment were unaware of the precise reason for this treatment, a positive history of macular oedema was not required for the diag nosis of previously treated macular oedema.
Statistical Analysis
Repeatability of the grading methods was assessed by the weighted kappa statistic29 and percentage exact agree ment. Risk factors for retinopathy and maculopathy were assessed according to the patient's worse eye. For depend ent variables employing ordinal scales a multivariate pro portional odds regression was used,30 and for dependent variables with a binary scale a multivariate logistic regres sion was employed.
RESULTS
The population prevalence of diabetes in the town was 10.8/1,000, the prevalence of non-insulin-treated diabetes being 6.7/1,000. Of the 215 patients with non-insulin treated diabetes who formed the target population for this study, 20 died during the study period and 5 moved away prior to their recruitment. (Four patients from the orig inally described population16 were excluded because they were found not to have diabetes.) Of the remaining 190 patients, 123 (123/190 = 65%) attended the research clinic. Information on ocular status was gathered from hospital records of a further 25 patients (9 of whom had died/moved), bringing the total for whom some infor mation on ocular status was known to 148 (148/ 199 = 74%). Mean age (±SD, minimum-maximum) for these subjects was 67.7 (± 11.9, 28-91) years, mean dia betic duration was 7.2 (±5.8, 1-35) years, mean age at diagnosis was 60.5 (± 12.8, 16-89) years, and 51 % of the subjects were males. Patients for whom no information on ocular status was available were on average slightly older, and were more likely to be female, although these differ ences did not reach the 5% probability level.
Photographic Grades of Retinopathy
Photographs of sufficient quality for grading were avail able for 197 eyes in 101 subjects. Where there were dis agreements in grading, final grades of retinopathy were reached by consensus. It is of interest to note that the inde pendent grading of the photographs by two ophthal mologists (I.S. and M.B.) was associated with a 'good' level of inter-observer agreement. For retinopathy grading the weighted kappa statistic29 and percentage exact agree ment were +0.71 and 77%, and for maculopathy grading these statistics were +0.60 and 88% respectively. The 101 subjects with grading-quality photographs were classified for retinopathy and maculopathy according to their worse eye. These results are presented in Table I . Fifty per cent (95% confidence interval (el) 41 % to 60%) of patients had background retinopathy and 3% (95% CI 1 % to 9%) had evidence of regressed (previously treated) prolifer ative retinopathy. Of those with background retinopathy Table I . Photographic grades of diabetic retinopathy and maculopathy in the worse eye for diabetic subjects Diabetic retinopathy (101 subjects) Retinopathy grades are those of the Wisconsin diabetic retinopathy grading method. 10 BGR, ba�kground retinopathy; PLR, proliferative retinopathy; 1.5-3, non-ischaemic background retinopathy; 4, background retinopathy with features of ischaemia; 6. 1, regressed proliferative diabetic retinopathy. Non-significant maculopathy, maculopathy not reaching the ETDRS standard for clinically significant maculopathy; clinically significant maculopathy, ETDRS clinically significant maculopathy;28 95% CI, 95% confidence interval for percentage prevalence. 
29% (15/51) had features of retinal ischaemia (grade 4).
No patients in this group had active proliferative ret inopathy or end-stage diabetic eye disease. Most patients had no maculopathy (79%, 95% CI 71 % to 87%); how ever, 5% (95% CI 2% to 12%) had ETDRS clinically sig nificant maculopathy requiring laser treatment. Only 1 patient had previously undetected diabetic macular oedema which required treatment.
Combined Clinical and Photographic Grades of Retinopathy
The results from the clinical examination of the patients in the research clinic were used to supplement the photo graphic grading data where photographs were of inade quate quality for grading. In line with the limitations of the clinical assessments, the categories for these grades have been collapsed, so that retinopathy is presented (Table II) as none, background retinopathy or proliferative retino pathy, and maculopathy is presented as a dichotomy of either none or ETDRS clinically significant maculopathy. In the combined group of 123 patients only 2% (95% CI 0.8% to 8%) had previous or present proliferative diabetic retinopathy, with 49% (95% CI 40% to 58%) having no retinopathy. Five per cent (95% CI 2% to 11%) of this group had ETDRS clinically significant diabetic maculopathy.
Combined Research Clinic and Hospital Records Data
Hospital records for 48 research clinic non-attenders were available and were reviewed. Of these 48 patients 25 had attended the Leicester Royal Infirmary ophthalmology department, and for 22 of these patients data on ret inopathy status were available. The records of the other 26 patients contained no information regarding their ocular status. Not surprisingly the patients attending the ophthal mology department appear to represent a group biased for J. M. SPARROW ET AL. ocular pathology. Fifty-nine per cent (13/22) had some retinopathy, with 14% (3/22) having past or present pro liferative diabetic retinopathy. Forty-one per cent (9/22) had clinically significant maculopathy. Combining all the available data provides the results presented in Table III , where it will be noted that 52% (95% CI 44% to 60%) of patients had some retinopathy, 4% (95% CI 2% to 9%) had proliferative disease, and 10% (95% CI 5% to 15%) had clinically significant diabetic maculopathy. Using these data it is possible to make a minimum estimate of the overall prevalence of retinopathy in the non-insulin treated diabetics of the town as a whole. If we assume that patients with unknown ocular status had no retinopathy, then the minimum estimates for the whole town suggest that at least 35% (75/215) had some retinopathy, with at least 3% (6/215) having proliferative disease and at least 7% (15/215) having clinically significant diabetic mac ulopathy. If we regard proliferative retinopathy or mac ulopathy requiring laser treatment as serious disease, then a reasonable minimum estimate for 'serious diabetic eye disease' in this group of non-insulin-treated diabetics would be about 10%. Conversely we may make the oppo site extreme assumption and regard all patients for whom no data were available as having retinopathy, which would give a maximum estimate for retinopathy of 67% (145/ 215) and for maculopathy of 40% (86/215).
Visual Acuity
Snellen visual acuity was known for 144 subjects; for 123 of these the vision was the best corrected acuity, and for the remainder the information was taken from the patient's hospital records, representing either the spec tacle or 'pin-hole' acuity, whichever was the better. The acuities in the subjects' better eye are presented in Table IV , where it is of note that 76% (95% CI 69% to 83%) of subjects had vision of 6/12 or better, and that 6% (95% CI 2% to 10%) of patients were blind (vision 6/60 or worse). 
Risk Factors fo r Retinopathy and Maculopathy
Potential risk factors for diabetic retinopathy and mac ulopathy were examined in a number of multivariate mod els. Subjects were classified according to their worse eye for these analyses. The multivariate analyses took the form of proportional odds regression30 for rank-ordered dependent variables, and standard logistic regression for binary dependent variables. �ll models were non-sequen tial, thus each variable in the model is adjusted for the effects of each other variable. Age, diabetic duration and systolic and diastolic blood pressure were treated as continuous variables, while sex, smoking habit and the use of systemic anti-hypertensive medication were treated as factors. Analyses were performed within the three sub groups described above, the analyses being tailored according to the availability of data within each group. The analyses are summarised in Tables V and VI . The main points of interest are that for diabetic retinopathy the duration of diabetes is an important risk factor, and further that a higher systolic blood pressure is associated with an increased risk of retinopathy. For diabetic maculopathy, duration of diabetes is likewise an important risk factor, with female sex, higher systolic blood pressure and the use of anti-hypertensive medication also contributing to the risk. Current cigarette smoking represented a marginal risk factor for maculopathy.
DISCUSSION
The findings of this survey of a total population confirm the importance of retinopathy and maculopathy in non insulin-treated diabetic patients, who comprised more than half the diabetics in Melton Mowbray. By augment ing the information gathered at the research clinic (attend ance rate 65%) with data from hospital records, the ocular status of 74% of the non-insulin-treated diabetic popUla tion was known. The attendance rate of the present group of non-insulin-treated patients was less than that for the previously reported insulin-treated group (86%), and there were also several non-insulin-treated patients lost to the study as a result of death or moving away from the study area. The lower attendance and greater population attrition were probably influenced by the fact that the mean age of the non-insulin-treated group was 20 years greater than the mean age of those using insulin,16 and further that the non-insulin-treated patients were examined in the second phase of the· study, thus being exposed to a longer delay between identification and recruitment. Among the non insulin-treated subjects there were no significant age or sex differences between attenders and non-attenders. From the combined studies there was information on the ocular status of 79% (216/330) of the surviving resident diabetics of the town.
In the various subgroups of the non-insulin-treated patients just under 50% of patients had no retinopathy in either eye, just under 50% had background retinopathy only in their worse eye, 2-4% had proliferative retino pathy in their worse eye, and 5-10% had clinically signifi cant maculopathy requiring laser treatment. The equivalent figures for the insulin-treated subjects were 50% with no retinopathy, 41 % with background retino pathy only, 9% with proliferative or advanced disease, and 14% with clinically significant * maculopathy. 16 These differences are consistent with previous reports in which diabetics on insulin treatment have higher rates of ret inopathy and maculopathy. 9, 11, 12, 14, 31 Previous population-based studies of non-insulin treated diabetics have provided similar results for ret inopathy. Comparison between the present study and the Wisconsin Epidemiologic Study of Diabetic Retinopathy (WESDR) of Klein et al. is the most relevant. Both were population-based studies and the same methods of quanti fication of retinopathy and maculopathy were employed, Klein et al. found slightly less background retinopathy (36%), the same prevalence of proliferative retinopathy (3%), but less macular oedema (3.7%) among their 696 non-insulin-treated patients, 1 1,14 In the present study our photographic grading and research clinic assessments demonstrated a comparable maculopathy prevalence of 5%, but inclusion of the data from hospital records on non attenders increased this prevalence to 10%. Not surpris ingly the hospital-based subgroup of non-attenders was biased towards those with more severe pathology.
Comparisons between studies become more difficult when the methods of assessing retinopathy are dissimilar; however, West et al. reported from a large multinational study a retinopathy prevalence of 21 % for any retinopathy and 1.4% for proliferative retinopathy among 2711 non insulin-treated patients.9 On the Island of Falseter, Denmark, Nielsen found background retinopathy in 38% and proliferative retinopathy in 3.3% of 306 diabetics treated with oral hypoglycaemic agents (mean age 71 years).8 Jerneld and Algvere reported on diabetics treated with oral hypoglycaemic agents from the Island of Got land, Sweden. In their random sample of 140 patients, 17% were found to have some retinopathy, and 1.4% to have proliferative retinopathy (mean age 73 years). 6 Segato et al. reported on a population-based sample of diabetics in the Veneto region of Northern Italy. Among the non-insulin-treated patients 25% were found to have retinopathy.12 In a Swiss national stratified popUlation sample retinopathy was found in only 13% of the 94 non insulin-treated subjects. 24 In a group of predominantly J. M. SPARROW ET AL.
(78%) non-insulin-treated elderly diabetics (age >60 years) in Oxford, Neil et al. found retinopathy in 26% of subjects. Interestingly, their finding of 76% of patients with visual acuity of 6/12 or better is identical to our own. 32 Our results have demonstrated a higher prevalence of retinopathy among non-insulin-treated diabetics than most previous studies. This is probably due to the use of a more sensitive method of diagnosis of retinopathy, i.e. stereo retinal photographs. Our findings are more compar able with those of Klein et al.11,14 who used the same photographic method of assessment.
Risk factors for background or proliferative retinopathy in the present study included longer duration of diabetes and higher systolic blood pressure (Table V) . Diabetic duration and increased systolic blood pressure have pre viously been reported as risk factors for retinopathy in non-insulin-treated patients,6,11.l8 although not all studies of non-insulin-treated patients have demonstrated a risk from hypertension.21
Risk factors for maculopathy included longer diabetic duration, female sex, higher systolic blood pressure, the use of anti-hypertensive medication, and a marginal effect of cigarette smoking (Table VI) . Previous data on risk fac tors for maculopathy are scarce. To our knowledge the only significant study of risk factors for maculopathy in non-insulin-treated diabetic patients in the WESDR, in which Klein et al. reported that macular oedema was asso ciated with longer diabetic duration, higher systolic blood pressure, and marginally with higher glycosylated haem oglobin.14 Systemic hypertension was found as a risk fac tor for macular oedema in the insulin-treated patients in Melton Mowbrai6 and a similar association has pre viously been reported in a small group of mixed dia betics.33 Our finding of a marginal effect of smoking in association with macular oedema is more controversial. There have been conflicting reports on the importance of smoking as a risk factor for diabetic retinopathy. 17,34,35 To our knowledge, however, there have been no previous studies specifically addressing the question of smoking as a risk factor for diabetic maculopathy. It is possible that the previously conflicting reports have resulted from fail ure to examine the effects of this possible risk factor on retinopathy and maculopathy separately. This finding war rants further investigation.
The present report on diabetic retinopathy and mac ulopathy in non-insulin-treated patients completes the total population study of diabetics resident in the town of Melton Mowbray. These two reports have provided valu able prevalence data for diabetic retinopathy and mac ulopathy in an English popUlation, which is known to be demographically representative of England and Wales as a whole. 27 Our data suggest that in Britain sight-threatening diabetic maculopathy, particularly among non-insulin treated diabetics, may be commoner than has previously been assumed from population-based studies in North America. Our findings confirm the importance of diabetic duration and systemic hypertension as risk factors for dia betic retinopathy and maculopathy, and suggest that ciga-rette smoking may be a risk factor specific to diabetic maculopathy.
